Mental Health

How AI can spot Alzheimer’s disease five years before diagnosis

Crunching the numbers: AI could help doctors to diagnose Alzheimer's sooner

P. Murali Doraiswamy
Professor of Psychiatry and Medicine, Duke University Medical Center
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on Mental Health?
The Big Picture
Explore and monitor how Mental Health is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Mental Health

Despite all the hype, artificial intelligence (AI) is not ready to replace doctors or automate brain surgery. But it can analyse immense amounts of data to help us better study, diagnose, treat and even prevent disease. Our hope is that it could reverse two decades of failed experimental therapies for Alzheimer’s disease.

Some of the most promising AI applications in medicine are in machine learning, a type of intelligence that uses algorithms to learn from patterns in data. Similar to how Siri learns your voice and Facebook can predict what videos you’ll like, learning algorithms can scan the retinas of diabetics and predict sight loss or sequence the genomes of entire towns to flag disease-causing genetic mutations.

We wanted to know what a new unbiased type of AI called “multilayer clustering” could tell us about Alzheimer’s. The push for Alzheimer’s treatments has been exciting and disappointing. In 20 years, we have yielded a greater understanding of the disease, yet failed to produce a successful preventive therapy.

Image: An illustration of the damage Alzheimer's inflicts on the brain

The many undefined subtypes of mild cognitive impairment, a precursor to Alzheimer’s, are partly to blame. When trials are testing one drug on numerous types of cognitive impairment, should we be surprised when more than 99% of those trials fail?

Scientists could much more precisely test the impact of investigational drugs if we could better identify and group those with similar brain changes and cognitive impairment. To do this, we applied a multilayer clustering algorithm to analyse dozens of data points from a US study called the Alzheimer’s Disease Neuroimaging Initiative, including cognition tests, brain scans and spinal fluid biomarkers. The samples were taken from 562 people with mild cognitive impairment followed for up to five years.

Have you read?

AI identified two groups of interest: those whose cogn­­­ition declined very rapidly and were at highest risk for Alzheimer’s; and those who saw little or no decline in their symptoms. A third group remained unclustered.

Brain scans of ‘rapid decliners’ showed twice the rate of atrophy as those for whom the disease was slow moving. Rapid decliners also progressed from mild cognitive impairment to dementia at five times the rate of those with a slow-moving disease. The full findings were published in July in Scientific Reports.

Looking at common traits of rapid decliners, it’s possible that in the future such algorithms could help doctors identify those most at risk from Alzheimer’s years before diagnosis.

These findings have direct implications for the design of future trials. We have known bits and pieces of this information – that there are dozens of genes that put people at risk or that certain brain changes put people at risk – but an unbiased tool such as an AI algorithm could put all of these pieces of information together, painting a picture that scientists might not have otherwise seen.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Mental HealthHealth and HealthcareGlobal Health
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

'Striking inequities' as global cancer burden grows, and other health stories you need to know this week

Shyam Bishen

February 14, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum